The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
about
Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptorMechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskApolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosisAntisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaLipid composition influences the shape of human low density lipoprotein in vitreous iceRerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.Detection of coronary atherosclerotic plaques with superficial proteoglycans and foam cells using real-time intrinsic fluorescence spectroscopyDeeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian populationAn apolipoprotein B100 mimotope prevents obesity in mice.Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.Tripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequencesApolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.Common and rare gene variants affecting plasma LDL cholesterolFatty liver and insulin resistance: not always linked.Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.Genetic variation and atherosclerosis.Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100.The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.Molecular characterization of Iranian patients with possible familial hypercholesterolemiaGenetics of familial hypercholesterolemia.Familial Hypercholesterolaemia in the Era of Genetic Testing.Low-density lipoprotein receptor activity in Epstein-Barr virus-transformed lymphocytes from heterozygotes for the D374Y mutation in the PCSK9 gene.Identification of the proteoglycan binding site in apolipoprotein B48.ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.The physical state of the LDL core influences the conformation of apolipoprotein B-100 on the lipoprotein surface.New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.Molecular description of familial defective APOB-100 in Malaysia.Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients.
P2860
Q24299117-41208CD0-9380-40F2-9279-1150A40572EEQ27003094-2D53C177-F74D-45B9-A168-33F408B5ACB5Q28278173-1FE54219-1585-4EF5-994A-3FF2E5720227Q33269609-53E0D258-9927-4AE9-A4CF-DE2D55430B75Q33605196-B48D41AC-A58B-4DD2-937D-47DCC5ACD131Q34074785-309B7628-2D29-4EE4-B868-E1168D08D863Q34201954-B58FEABF-1ED1-43D1-B6C4-4E1F9C5C23DFQ34629216-3D0AD6EB-9B86-44C0-870E-C3088CABCDD2Q35047636-9EE2DEB1-5A7F-495A-86DF-3DCD84B63B57Q35790784-317CFC58-6A1C-4192-8181-2F83413A4061Q36357399-38216CE3-4B8E-4D8E-A14B-69486DAF1104Q36359516-2BDD9E00-F760-4585-9656-DE48CB0E6FC8Q36386406-4745DE12-9569-41D1-A313-EAAD39134473Q36536256-A3BF0824-8ACE-466E-88C9-37BE6A79ED48Q36617485-E5D44C66-DE81-42C8-9996-FC57BFE217C1Q36634114-298BDC00-B0D2-468F-85D1-724C92AE4B1AQ36653061-11B140B6-6CA9-4CEE-8735-4491E549A61CQ36711327-9D8CE4FA-19D1-4718-820D-FF0C85B3B96DQ36742407-8EDC09A5-2296-45E2-B350-E703FA0F16CCQ37091275-14A0F813-17B4-4D97-A216-9816B9694262Q37172163-518F0B85-0C96-4A9A-A381-988A355ECCCFQ37361773-A90043D0-F71A-44A5-BE4A-62C7EFA9B5E4Q37363150-0913CD10-1820-4C59-B3A1-97BBE3EF718CQ37608495-26031959-D2A1-4CC9-86E2-34390E9FDEB1Q37665476-BDCE3DE8-B033-452E-827D-9948AC4764F2Q38266454-E89F7C46-0C9D-4E91-BA57-718F0F31FD93Q38364881-CECB0B82-47EC-4FAF-97AD-A0388DB88324Q38784635-76DFBB08-F12E-4B39-886F-9E4723CB219FQ40267328-CAE8DB74-ED48-4D74-97A2-7E7532C6729EQ40724243-980EB16F-DD99-4FDD-A64D-5C8897D46C1CQ44138808-27EF5FFD-8913-4AEA-9365-F9572C3BB751Q44891596-F0B27C5E-E505-4437-BD8F-859BAA68340BQ48130479-D3F4C08B-B527-485D-82D7-716A71512F08Q50899557-FFD4A87F-5CE4-4C2D-8188-C89236DDE962Q55300111-55674C83-E3DA-4BB2-BE45-78E3AFE9C2B4
P2860
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@ast
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@en
type
label
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@ast
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@en
prefLabel
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@ast
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@en
P2093
P2860
P356
P1476
The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
@en
P2093
Innerarity TL
Nilsson-Ehle P
P2860
P304
P356
10.1074/JBC.M008890200
P407
P50
P577
2000-12-13T00:00:00Z